Taught a lesson by taut skin
暂无分享,去创建一个
[1] D. Wuttge,et al. Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor , 2012, Scandinavian journal of rheumatology.
[2] L. Mouthon,et al. Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis , 2011, Clinical reviews in allergy & immunology.
[3] M. Mayes,et al. HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis. , 2011, Arthritis and rheumatism.
[4] L. Mouthon,et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients , 2007, Annals of the rheumatic diseases.
[5] W. Whittier,et al. Renal biopsy: update , 2004, Current opinion in nephrology and hypertension.
[6] Richard W. Martin,et al. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. , 2002, Arthritis and rheumatism.
[7] T. Medsger,et al. Long-Term Outcomes of Scleroderma Renal Crisis , 2000, Annals of Internal Medicine.
[8] T. Medsger,et al. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. , 1998, Arthritis and rheumatism.
[9] A. Silman,et al. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. , 1996, British journal of rheumatology.
[10] V. Steen. Scleroderma renal crisis. , 1996, Rheumatic diseases clinics of North America.
[11] J. Donohoe. Scleroderma and the kidney. , 1992, Kidney international.
[12] J. Costantino,et al. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. , 1990, Annals of internal medicine.
[13] T. Medsger,et al. Normotensive renal failure in systemic sclerosis. , 1989, Arthritis and rheumatism.
[14] T. Medsger,et al. Factors Predicting Development of Renal Involvement in Progressive Systemic Sclerosis , 1984 .
[15] T. Medsger,et al. Factors predicting development of renal involvement in progressive systemic sclerosis. , 1984, The American journal of medicine.
[16] T. Medsger,et al. Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25‐YEAR EXPERIENCE WITH 68 CASES , 1983, Medicine.
[17] A. Masi,et al. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.
[18] Tien Yin Wong,et al. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. , 2005, British medical bulletin.
[19] C. Kitiyakara,et al. Malignant hypertension and hypertensive emergencies. , 1998, Journal of the American Society of Nephrology : JASN.
[20] C. Denton,et al. Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases. , 1994, British journal of rheumatology.
[21] A. Nissenson,et al. Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. , 1990, The Quarterly journal of medicine.